Nan Zhang

7PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 03, 2026
Chemotherapy induces an IL1β-dependent neutrophil recruitment and activation that promote chemoresistance in metastatic ovarian cancer.

|Jul 14, 2025
Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer.

Hao Nie, Liping Liao, Rafal J Zielinski

|Nov 21, 2024
Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer.

Brennah Murphy, Taito Miyamoto, Bryan S Manning

|Jul 09, 2024
Intraperitoneal activation of myeloid cells clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer.

Brennah Murphy, Taito Miyamoto, Bryan S Manning

|Oct 29, 2021
LYVE1+ macrophages of murine peritoneal mesothelium promote omentum-independent ovarian tumor growth.

Nan Zhang, Seung Hyeon Kim, Anastasiia Gainullina

|May 04, 2019
Expression of factor V by resident macrophages boosts host defense in the peritoneal cavity.

Nan Zhang, Rafael S Czepielewski, Nicholas N Jarjour

Pageof 2

Frequent Collaborators

2 joint publications

Rafael S Czepielewski

2 joint publications

Rugang Zhang

2 joint publications

Brian T Saunders

2 joint publications

Gwendalyn J Randolph